Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  4Sc AG    VSC   DE000A14KL72

4SC AG

(VSC)
  Report  
Real-time Quote. Real-time Tradegate - 04/24 11:36:06 am
3.51 EUR   +1.74%
04/184SC : provides Q1 2019 update
EQ
04/154SC AG : quaterly earnings release
04/084SC AG : Domatinostat's mode of action in Merkel cell carcinoma
EQ
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

4Sc AG : quaterly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/15/2019 | 09:15am EDT

The company will report its earnings for Q1 2019 on 04/18/2019. Generally, the company reports earnings in line with the consensus. In recent months, the analysts from Thomson Reuters consensus have revised their EPS estimates downward.


© MarketScreener.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on 4SC AG
04/184SC : provides Q1 2019 update
EQ
04/154SC AG : quaterly earnings release
04/084SC AG : Domatinostat's mode of action in Merkel cell carcinoma
EQ
04/02Dynavaxs SD-101 and 4SCs Domatinostat Demonstrate Synergy and Induce a System..
AQ
04/014SC AG : Dynavax's SD-101 and 4SC's Domatinostat Demonstrate Synergy and Induce ..
EQ
04/014SC : Dynavax's SD-101 and 4SC's Domatinostat Demonstrate Synergy and Induce a S..
AQ
03/204SC : provides results for financial year 2018 and outlook
EQ
03/154SC AG : annual earnings release
03/134SC AG : Conference call to be hosted on 20 March 2019 to present the annual rep..
EQ
03/074SC AG : 9 upcoming conferences and roadshows
EQ
More news
Financials (€)
Sales 2019 2,55 M
EBIT 2019 -19,1 M
Net income 2019 -20,1 M
Finance 2019 5,30 M
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales 2019 39,4x
Capi. / Sales 2020 52,9x
Capitalization 106 M
Chart 4SC AG
Duration : Period :
4Sc AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 4SC AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 6,30 €
Spread / Average Target 83%
EPS Revisions
Managers
NameTitle
Jason Loveridge Chief Executive Officer
Clemens M. Doppler Chairman-Supervisory Board
Susanne Danhauser-Riedl Chief Medical Officer
Manfred Rüdiger Member-Supervisory Board
Helmut Jeggle Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
4SC AG23.88%119
IQVIA HOLDINGS INC17.95%27 077
CELLTRION, INC.--.--%24 686
LONZA GROUP21.91%22 655
INCYTE CORPORATION15.84%16 158
EXACT SCIENCES CORPORATION48.87%11 814